Xenotransplantation elicits salient tumorigenicity of adult T‐cell leukemia‐derived cells via aberrant AKT activation |
| |
Authors: | Kazunori Yamaguchi Tomoka Takanashi Kentaro Nasu Keiichi Tamai Mai Mochizuki Ikuro Satoh Shoji Ine Osamu Sasaki Kennichi Satoh Nobuyuki Tanaka Hideo Harigae Kazuo Sugamura |
| |
Affiliation: | 1. Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan;2. Department of Cancer Science, Tohoku University Graduate School of Medicine, Sendai, Japan;3. Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan;4. Division of Cancer Biology and Therapeutics, Miyagi Cancer Center Research Institute, Natori, Japan;5. Department of Pathology, Miyagi Cancer Center, Natori, Japan;6. Division of Hematology, Miyagi Cancer Center, Natori, Japan;7. Division of Cancer Stem Cells, Miyagi Cancer Center Research Institute, Natori, Japan |
| |
Abstract: | The transplantation of human cancer cells into immunodeficient NOD/SCID/IL‐2Rγcnull (NOG) mice often causes highly malignant cell populations like cancer stem cells to emerge. Here, by serial transplantation in NOG mice, we established two highly tumorigenic adult T‐cell leukemia‐derived cell lines, ST1‐N6 and TL‐Om1‐N8. When transplanted s.c., these cells formed tumors significantly earlier and from fewer initial cells than their parental lines ST1 and TL‐Om1. We found that protein kinase B (AKT) signaling was upregulated in ST1‐N6 and TL‐Om1‐N8 cells, and that this upregulation was due to the decreased expression of a negative regulator, INPP5D. Furthermore, the introduction of a constitutively active AKT mutant expression vector into ST1 cells augmented the tumorigenicity of the cells, whereas treatment with the AKT inhibitor MK‐2206 attenuated the progression of tumors induced by ST1‐N6 cells. Collectively, our results reveal that the AKT signaling pathway plays a critical role in the malignancy of adult T‐cell leukemia‐derived cells. |
| |
Keywords: | Adult T‐cell leukemia proto‐oncogene protein Akt severe combined immunodeficient mice tumor‐initiating cells xenotransplantation |
|
|